Ascorbic Acid

證據等級: L5

預測適應症: 10 個

Ascorbic Acid: From Vitamin C Deficiency to Non-Syndromic Esophageal Malformation

One-Sentence Summary

Ascorbic Acid is the active form of Vitamin C, an essential nutrient whose primary classical indication is the prevention and treatment of vitamin C deficiency (scurvy) and nutritional supplementation. The TxGNN model ranks Non-Syndromic Esophageal Malformation as its top novel repurposing prediction with a model score of 99.96%, yet no clinical trials and no supporting publications exist for this specific direction — placing this prediction at the lowest possible evidence tier (L5).

Quick Overview

Item	Content
Original Indication	Vitamin C deficiency (scurvy) and nutritional supplementation
Predicted New Indication	Non-Syndromic Esophageal Malformation
TxGNN Prediction Score	99.96%
Evidence Level	L5
Saudi Arabia Market Status	Not marketed
Number of Authorizations	0
Recommended Decision	Hold

Why is This Prediction Reasonable?

Currently, detailed mechanism of action data is not available in this evidence pack. Based on established pharmacology, Ascorbic Acid (Vitamin C) is an obligatory co-factor for prolyl-4-hydroxylase and lysyl hydroxylase — enzymes that catalyze the post-translational modifications essential for collagen triple-helix stability and cross-linking. It also acts as a potent water-soluble antioxidant, an enhancer of non-heme iron absorption, and crucially, a co-factor for TET family dioxygenases that mediate epigenetic DNA demethylation. This last role has growing relevance to developmental biology, as TET-mediated epigenetic reprogramming is critical during early embryogenesis.

Non-syndromic esophageal malformation encompasses congenital structural anomalies of the esophagus — including esophageal atresia and tracheo-esophageal fistula — occurring without associated syndromic features. The theoretical basis for the TxGNN prediction rests on two possible mechanistic threads: first, that Vitamin C's co-factor role in collagen maturation could influence esophageal connective tissue formation during embryonic development; second, that TET-mediated epigenetic programming could modulate foregut progenitor cell differentiation. Supporting the developmental importance of Vitamin C more broadly, knockout studies of the ascorbic acid brain transporter (Slc23a1) in mice confirm that Vitamin C availability is essential for perinatal survival.

However, the link to esophageal malformation specifically is entirely speculative. These structural congenital defects arise from embryological patterning failures governed by genetic programs — principally Shh, Wnt, and Notch signaling cascades — rather than nutritional substrate availability. No esophageal malformation phenotype has been reported in any Vitamin C-deficient animal model, and no human epidemiological data associate maternal Vitamin C status with this condition. The high TxGNN score most likely reflects broad network connectivity between Vitamin C metabolism nodes and esophageal disease nodes in the underlying knowledge graph, rather than a specific pharmacological relationship. This prediction should be treated as a hypothesis-generating signal only.

Clinical Trial Evidence

Currently no related clinical trials registered for ascorbic acid in non-syndromic esophageal malformation.

Literature Evidence

Currently no related literature available for this indication.

Safety Considerations

Please refer to the package insert for safety information.

Conclusion and Next Steps

Decision: Hold

Rationale: Non-syndromic esophageal malformation is a structural congenital defect with genetic and embryological origins that are mechanistically disconnected from the pharmacological actions of Vitamin C supplementation. With zero supporting preclinical or clinical evidence, this repurposing direction cannot progress without fundamental hypothesis validation from the ground up.

To proceed, the following is needed:

Animal model studies examining whether maternal Vitamin C deficiency or high-dose supplementation during early gestation affects the incidence or severity of esophageal malformations
Epidemiological data assessing whether maternal Vitamin C status correlates with non-syndromic esophageal malformation incidence in human cohorts
Mechanistic studies clarifying whether esophageal foregut morphogenesis is sensitive to ascorbic acid availability — particularly via collagen maturation or TET-mediated epigenetic pathways
Complete drug mechanism of action (MOA) data from DrugBank (currently absent from this dataset)
Safety profile, key warnings, and contraindications retrieved from the product package insert
Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.